Brind.

Avi Pelossof joined NeoGen's Board of Directors while working at a company acquired by Werfen. Abbott is marketing a molecular test related to Pelossof's prior work.

1 report, 1 independent Updated Aug 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Avi Pelossof joined NeoGen's Board of Directors while working at a company acquired by Werfen. Abbott is marketing a molecular test related to Pelossof's prior work.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Business WireNeogen Announces Board Transition with Appointment of Avi Pelossof and the Retirement of William Boehm LANSING, Mich., August 14, 2025--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG), an innovat